Stenting for Localised Arterial Stenoses in the Aorto-iliac Segment  by Saha, S et al.
Eur J Vasc Endovasc Surg 22, 37–40 (2001)
doi:10.1053/ejvs.2001.1409, available online at http://www.idealibrary.com on
Stenting for Localised Arterial Stenoses in the Aorto-iliac Segment
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Objective: to determine complications and patency following angioplasty (PTA) and stenting of aorto-iliac stenoses.
Setting: District General Hospital in U.K.
Design: prospective observational study.
Patients and methods: between December 1994 and June 2000, 50 patients (38 men), median age 64 (41–89) years
underwent aorto-iliac stenting. A total of 61 stents were placed. Indications were intermittent claudication in 38 and
rest pain, ulceration or gangrene in 12. Sites stented were aorta 11, common iliac artery 32, external iliac artery 14,
common and external iliac arteries two. Bilateral iliac procedures were carried out in nine. Two stents were used to
correct residual stenoses after aortic stenting. Some 11 recurrent stenoses were treated. The other reasons for stenting
were residual stenoses greater than 30% after PTA, tight calcified stenoses or when a stenosed iliac artery was being
used as a donor prior to crossover or femoropopliteal bypass.
Results: two immediate technical failures occurred due to malposition. Residual stenoses were corrected by PTA. Two
further patients sustained minor complications. None of the aortic stents occluded through two required secondary
procedures. Primary-assisted patency was thus 100% at three years. Primary patency following iliac stenting for
claudication and critical ischaemia were 97% and 86% at three years repectively.
Conclusion: PTA and stenting of aorto-iliac stenoses can be safely achieved with durable results.
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Introduction The aim of this study is to describe our results of
PTA with primary stenting for stenoses affecting the
Percutaneous transluminal angioplasty (PTA) is aorta and iliac arteries.
usually a durable procedure in the majority of patients
with localised stenosis of the iliac arteries. However,
treatment of restenoses, long and tight stenoses, dis-
Patients and Methodssections and occlusions have all been shown to be
associated with poorer results and more complications
A radiology computer database was used to identifyfollowing PTA alone.1–3 Under these circumstances
consecutive patients who underwent attempted place-PTA plus primary stenting is an attractive alternative.
ment of aorto-iliac stents for stenotic lesions betweenPrimary stenting of severe short stenoses of the
December 1994 and June 2000. Some 61 stents wereinfra- or juxta-renal aortic segment is also an attractive
placed in 50 patients (38 men and 12 women) withminimally invasive alternative to conventional sur-
median age of 64 (range 41–89) years. During the samegery.4,5
time period 167 patients underwent iliac PTA withoutWe have previously reported significant technical
stenting. Of the patients having stents all underwentdifficulties and complications associated with stenting
a full clinical assessment including ankle-brachial pres-complete iliac occlusions.6,7 Furthermore there is a
sure index (ABPI) and an intravenous digital sub-rapid fall in patency within the first 6 months, but
traction angiography (IV DSA) prior to intervention.nearly half of the patients can expect long-term
Eleven patients had aortic stenoses. All had inter-patency.
mittent claudication and one bilateral leg ulcers. Some
28 patients had 37 iliac arteries stented for claudication.
Bilateral symptoms were present in nine. A further 11
∗ Please address all correspondence to: R. B. Galland, Consultant patients required 11 stents for rest pain (3) or ulcerationSurgeon, Royal Berkshire Hospital, London Road, Reading
RG1 5AN, U.K. and gangrene (8). Some 32 lesions were in the common
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iliac artery, 14 in the external and two in both common log rank test using the statistical computing package
Minitab (version 13.1).8and external. Two further iliac stents were used fol-
lowing initially successful aortic stenting. They are
described later and not included in the analysis of iliac
stent patency. Results
All aortic stenoses were treated with primary stent-
ing. Our indications for iliac stenosis stenting were Stent deployment and placement was technically suc-
recurrent stenosis after previous PTA, residual stenosis cessful in all but two of 61 procedures (97%). In two
of greater than 30% after PTA, very tight or calcific cases malposition occurred, one in an aortic and the
stenoses where significant elastic recoil was anticipated other in a common iliac stenosis. Flow through the
and PTA complicated by iliac artery dissection. In vessel was maintained and in both instances the sten-
addition we placed stents when the iliac artery was osis was angioplastied with good result. Three patients
used as a donor vessel prior to, for example, femoro- had mild residual stenosis, including one following
femoral cross over grafting. aortic stenting. None of these required further radio-
logical or surgical intervention. Access to the stenosed
segment was difficult in three limbs due to obesity,Stent technique
tortuosity of the iliac artery and fibrosis in the groin
from previous surgery.PTA and stenting was performed via the transfemoral
Minor procedural complications were encounteredroute using Seldinger technique under local
in two cases. One patient suffered a vasovagal attackanaesthetic. Intravenous sedation and analgesia was
immediately after the procedure. Another patient de-given when necessary. Lesions were crossed using
veloped a groin haematoma. This did not requirehydrophilic guide wires which were exchanged for
treatment.heavy duty guide wires. Heparin, 3000 units, was
given intra-arterially. Only lesions thought to be very
tight were pre-dilated and then to 1 mm less than the
intended size. Stent size was estimated from DSA. Follow-up
Four different types of stent were used – Palmaz
(Johnson and Johnson, Warren, New Jersey, U.S.A.), All of the aortic stents remained patent. However,
in two patients claudication developed following theWallstent (Boston Scientific, Schneider, Bullach, Swit-
zerland), Jostent (Jomed, Rangendingen, Germany) procedure and each required iliac stenting for a sten-
osis at the origin of the common iliac artery one andand AVE stent (Medtronic AVE, Santa Rosa, CA,
U.S.A.). Stent deployment was deemed technically four months following the initial stent. They ex-
perienced no further symptoms following this andsuccessful if there was less than 30% residual stenosis
and the stent was in the correct position on the post- the stents remained patent. Thus, primary-assisted
patency at three years was 100%.procedure angiogram. Balloon-expanded stents (Pal-
maz, AVE) were used preferentially for severely cal- Only two iliac stents have so far occluded. One
occurred 1 week after stenting for intermittent clau-cified lesions and lesions adjacent to the aortic
bifurcation. Self-expanding stents (Wallstent, Jostent) dication, and was successfully treated with throm-
bolysis. This re-occluded 21 months later and requiredwere usually placed for long-segment disease or tor-
tuous iliac artery. Stent length ranged from 3 to 7 cm a femoro-femoral cross over graft. In another patient
with rest pain, the left external iliac stent which wasand diameter from 6 to 14 mm. Pressure gradiant
measurements were not carried out routinely. placed to improve flow above a femoropopliteal graft
occluded 7 months after intervention. The patient didPatients not already taking aspirin were prescribed
a daily dose of 75 mg. Routine clinical examination not develop symptoms and no further procedure was
undertaken. Table 1 shows probability of patency forand ABPI were carried out 6–8 weeks following the
procedure. In our early cases (up to November 1996) stents placed for intermittent claudication or rest pain,
ulceration and gangrene. There was no difference be-IV DSA was carried out 6 and 12 months after stenting.6
Subsequently, patients were clinically assessed an- tween the two groups (p=0.30).
Twelve patients underwent stent placement for crit-nually and angiography, duplex examination or pres-
sure gradient measurements were only carried out if ical ischaemia (11 iliac, one aortic). All limbs were
salvaged by stenting or in five patients in a com-clinically indicated.
Patency rates were obtained by the Kaplan–Meier bination of stenting and infrainguinal bypass pro-
cedures.method and differences were compared using the
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Table 1. Primary assisted patency following iliac stent insertion for intermittent claudication or critical limb ischaemia (rest pain,
ulceration or gangrene).
Interval Number at Occluded Died Lost Censored Probability Kaplan–Meier
(months) risk of patency estimate of patency
Intermittent claudication
0–1 37 1 0 0 0 0.97 0.97
1–12 31 0 0 1 4 1 0.97
12–24 27 0 0 0 4 1 0.97
24–36 22 0 0 0 5 1 0.97
36–48 9 0 0 0 13 1 0.97
Critical limb ischaemia
0–1 11 0 1 0 0 1 1
1–12 7 1 2 0 2 0.86 0.86
12–24 6 0 1 0 0 1 0.86
24–36 5 0 1 0 0 1 0.86
One death occurred within 30 days of stent insertion. with iliac stenoses.9,10 Whether addition of stenting
This patient presented with a critically ischaemic foot improves long term results is unclear, but some authors
and had a right common iliac stent prior to a right to advocate routine stent placement after an otherwise
left femoro-femoral crossover graft which occluded on uncomplicated PTA in an attempt to prevent recurrent
the first postoperative day. This required an exploration disease.11 A recent meta-analysis of all studies of an-
of the graft and the patient died suddenly from myo- gioplasty and stenting12 has shown that the majority
cardial infarction on the second postoperative day. of stents are placed for stenotic lesions. There was a
There were four late deaths, all in patients initially pre- 5% improvement in immediate technical success rate
senting with critical ischaemia. Two patients died of and a 7–11% improvement in 4-year primary patency
malignant disease 11 and 4 months after stenting. The rate with stenting after iliac angioplasty compared
others died of chronic obstructive airways disease 6 and with iliac angioplasty alone. However, in a randomised
33 months after the procedure. trial of PTA versus PTA and selective stenting no
significant differences emerged between the two
groups.13 In this series approximately 80% of lesions
were iliac stenoses greater than 50%. These authors
Discussion suggested that PTA and stenting should be reserved
for “failures” of PTA alone. Our intention was to
We achieved a high success rate with a low incidence of treat recurrent and technically difficult stenoses withcomplications in stenting iliac stenoses. This contrasts
stenting. We also decided to place stents when thewith our experience with stenting of iliac occlu-
iliac artery was to be used as a donor vessel forsions.6,7 However, on an anatomical and pathological
subsequent bypass. Our indications for stenting werebasis this difference is not unexpected, as stenting
very conservative. During the period of our studystenotic lesions as an adjunct to angioplasty is tech-
23% of patients undergoing iliac PTA for stenosisnically easier than with occlusions. The passage of a
underwent stenting. This is lower than the 43% ofguidewire across the lesion is the critical step and it
patients who underwent “selective” stenting basedoften fails in occlusions. In our series of 51 patients
on elastic recoil or “inappropriate results” found onwith iliac occlusions 12 of the 13 unsuccessful attempts
angiography following PTA alone.13 Routine stentingat stenting were due to a failure to cross the lesion.6 In
as an adjunct to angioplasty has financial implications.7the present series all lesions were successfully crossed
Concern has also been raised about the possibility ofwith subsequent stent deployment. Of 38 patients who
increased myointimal hyperplasia after stent insertionhad successful stenting for iliac occlusions, seven had
with an increased risk of re-stenosis.14,15 We adopted amajor immediate complications,6,7 whereas only two
selective policy whereby re-stenoses, acute dissectionminor procedural complications were noted in this
following PTA, and those at high risk of re-stenosesseries. Two stents migrated proximally. We have con-
(calcific, tight or long segment stenoses) were selectedsidered these as technical failures, although PTA at
for stent placement. Stents were also placed inthe time of the procedure retrieved the situation and
localized iliac stenoses, to improve inflow prior tothe stents remain patent.
femoro-femoral crossover grafts or femoropoplitealIndications for stenting in iliac stenoses are evolving;
PTA alone gives excellent results for most patients bypass. The follow-up in this series is modest but
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